Dr. Guy Harmelin

Chief Investment Officer, Advanced Technology at MGX

About

Dr. Guy Harmelin is a physician-turned-investor and serial biotech founder (RondinX/BiomX NYSE; Ayala Pharmaceuticals Nasdaq) with Oxford Nanopore board experience and a $750K–$10M life sciences and industrials investment focus.

Website ↗

Invests in

AI & Machine LearningBiotechData & InfrastructureRoboticsSemiconductors

Colleagues at MGX

Ahmed Yahia Al Idrissi

Managing Director and Chief Executive Officer at MGX

Ali Osman

Chief Investment Officer, Artificial Intelligence at MGX

Omar Alismail

Chief Investment Officer, Semiconductors & Infrastructure at MGX